Published in Mod Pathol on June 01, 1998
Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med (2010) 13.33
Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas. J Clin Invest (2004) 3.92
Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease. Hepatology (2010) 2.86
Endpoints and clinical trial design for nonalcoholic steatohepatitis. Hepatology (2011) 2.44
Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Aliment Pharmacol Ther (2010) 2.28
Pathology of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol (2010) 2.25
Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease. BMC Gastroenterol (2006) 1.86
Histopathology of nonalcoholic fatty liver disease. World J Gastroenterol (2010) 1.75
Pathogenesis and management issues for non-alcoholic fatty liver disease. World J Gastroenterol (2007) 1.59
Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis. World J Gastroenterol (2007) 1.50
Hepatocellular ballooning in NASH. J Hepatol (2010) 1.48
Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease. BMC Gastroenterol (2006) 1.47
Diagnosis and evaluation of nonalcoholic fatty liver disease. Exp Diabetes Res (2011) 1.42
Clinical usefulness of biochemical markers of liver fibrosis in patients with nonalcoholic fatty liver disease. World J Gastroenterol (2005) 1.30
Nonalcoholic fatty liver disease and serum lipoproteins: the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis (2013) 1.29
Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J Gastroenterol (2014) 1.20
Computed tomography scans in the evaluation of fatty liver disease in a population based study: the multi-ethnic study of atherosclerosis. Acad Radiol (2012) 1.18
Effects of liver biopsy sample length and number of readings on sampling variability in nonalcoholic Fatty liver disease. Clin Gastroenterol Hepatol (2008) 1.08
Circulating microparticles as disease-specific biomarkers of severity of inflammation in patients with hepatitis C or nonalcoholic steatohepatitis. Gastroenterology (2012) 1.06
Generalizability of the nonalcoholic steatohepatitis Clinical Research Network histologic scoring system for nonalcoholic fatty liver disease. J Clin Gastroenterol (2011) 1.02
The relevance of liver histology to predicting clinically meaningful outcomes in nonalcoholic steatohepatitis. Clin Liver Dis (2012) 0.97
Hepatocyte-specific deletion of Janus kinase 2 (JAK2) protects against diet-induced steatohepatitis and glucose intolerance. J Biol Chem (2012) 0.94
Association between Wisteria floribunda agglutinin-positive Mac-2 binding protein and the fibrosis stage of non-alcoholic fatty liver disease. J Gastroenterol (2014) 0.93
Role of liver biopsy in nonalcoholic fatty liver disease. World J Gastroenterol (2014) 0.92
Comparing morphometric, biochemical, and visual measurements of macrovesicular steatosis of liver. Hum Pathol (2010) 0.90
Digital quantification is more precise than traditional semiquantitation of hepatic steatosis: correlation with fibrosis in 220 treatment-naïve patients with chronic hepatitis C. Dig Dis Sci (2010) 0.89
Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome. World J Gastroenterol (2014) 0.89
Establishment of a general NAFLD scoring system for rodent models and comparison to human liver pathology. PLoS One (2014) 0.89
Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J Gastroenterol (2014) 0.88
Correlation of Body Mass Index and Serum Parameters With Ultrasonographic Grade of Fatty Change in Non-alcoholic Fatty Liver Disease. Iran Red Crescent Med J (2014) 0.88
Telmisartan improves nonalcoholic steatohepatitis in medaka (Oryzias latipes) by reducing macrophage infiltration and fat accumulation. Cell Tissue Res (2011) 0.86
Serum Fucosylated Haptoglobin as a Novel Diagnostic Biomarker for Predicting Hepatocyte Ballooning and Nonalcoholic Steatohepatitis. PLoS One (2013) 0.86
Effect of insulin-metformin combination on hepatic steatosis in patients with type 2 diabetes. J Diabetes Complications (2007) 0.86
Novel equation to determine the hepatic triglyceride concentration in humans by MRI: diagnosis and monitoring of NAFLD in obese patients before and after bariatric surgery. BMC Med (2014) 0.85
Controversies in the Diagnosis and Management of NAFLD and NASH. Gastroenterol Hepatol (N Y) (2014) 0.84
Effect of insulin versus triple oral therapy on the progression of hepatic steatosis in type 2 diabetes. J Investig Med (2012) 0.81
The spontaneous course of liver enzymes and its correlation in nonalcoholic fatty liver disease. Dig Dis Sci (2012) 0.79
Transitions of histopathologic criteria for diagnosis of nonalcoholic fatty liver disease during the last three decades. World J Hepatol (2014) 0.79
Oral choline tolerance test as a novel noninvasive method for predicting nonalcoholic steatohepatitis. J Gastroenterol (2013) 0.78
Current status and agenda in the diagnosis of nonalcoholic steatohepatitis in Japan. World J Hepatol (2010) 0.78
Relevance of low testosterone to non-alcoholic fatty liver disease. Cardiovasc Endocrinol (2015) 0.77
Sonographic assessment of fatty liver: intraobserver and interobserver variability. Int J Clin Exp Med (2014) 0.76
Frozen section diagnosis in donor liver biopsies: observer variation of semiquantitative and quantitative steatosis assessment. Virchows Arch (2012) 0.76
Dual-photon microscopy-based quantitation of fibrosis-related parameters (q-FP) to model disease progression in steatohepatitis. Hepatology (2017) 0.75
In the non-cirrhotic stage of nonalcoholic steatohepatitis, angioarchitecture of portal veins and lobular architecture are maintained. Virchows Arch (2013) 0.75
Hypocholesterolemic Effects of Probiotic Mixture on Diet-Induced Hypercholesterolemic Rats. Nutrients (2017) 0.75
Advanced hepatic fibrosis and cirrhosis due to nonalcoholic fatty liver disease in Sri Lankan children: a preliminary report. Hepatol Int (2008) 0.75
Noninvasive Markers of Fibrosis and Inflammation in Nonalcoholic Fatty Liver Disease. Curr Hepatol Rep (2016) 0.75
Histology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in Adults and Children. Clin Liver Dis (2015) 0.75
Assessment of liver fat in an obese patient population using noncontrast CT fat percent index. Clin Imaging (2014) 0.75
Current Modalities of Fibrosis Assessment in Non-alcoholic Fatty Liver Disease. J Clin Transl Hepatol (2017) 0.75
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology (1999) 11.76
Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes (2001) 9.67
The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase. Science (1999) 7.60
Primary liver abscess due to Klebsiella pneumoniae in Taiwan. Clin Infect Dis (1998) 7.51
Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med (1999) 5.65
Septic metastatic lesions of pyogenic liver abscess. Their association with Klebsiella pneumoniae bacteremia in diabetic patients. Arch Intern Med (1991) 3.21
A prospective clinical trial of pulse therapy with glucocorticoid and cyclophosphamide in moderate to severe paraquat-poisoned patients. Am J Respir Crit Care Med (1999) 2.68
A prospective, multi-center clinical trial of the Taylor intragastric balloon for the treatment of morbid obesity. Am J Gastroenterol (1990) 2.59
Klebsiella pneumoniae liver abscess associated with septic endophthalmitis. Arch Intern Med (1986) 2.57
Clinical features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis (2001) 2.56
Skin and soft-tissue manifestations of Shewanella putrefaciens infection. Clin Infect Dis (1997) 2.45
Application of digital image analysis and flow cytometry to enumerate marine viruses stained with SYBR gold. Appl Environ Microbiol (2001) 2.30
Extremely high prevalence of nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae among children in Kaohsiung, Taiwan. J Clin Microbiol (1998) 2.24
The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients. Support Care Cancer (2000) 2.12
Isolation of high-affinity peptide antagonists of 14-3-3 proteins by phage display. Biochemistry (1999) 2.10
Proteolysis-independent regulation of PI3K by Cbl-b-mediated ubiquitination in T cells. Nat Immunol (2001) 2.02
Identification of a disease resistance locus in Arabidopsis that is functionally homologous to the RPG1 locus of soybean. Plant J (1993) 2.01
Mushroom poisoning--from diarrhea to liver transplantation. Am J Gastroenterol (2001) 1.93
Recognition and ubiquitination of Notch by Itch, a hect-type E3 ubiquitin ligase. J Biol Chem (2000) 1.88
Novel mitochondrial DNA deletion found in a renal cell carcinoma. Genes Chromosomes Cancer (1996) 1.81
Eosinophilic meningitis caused by Angiostrongylus cantonensis: report of 17 cases. Am J Med (2001) 1.76
Hepatic iron and nonalcoholic fatty liver disease. Hepatology (1999) 1.70
Pulse therapy with cyclophosphamide and methylprednisolone in patients with moderate to severe paraquat poisoning: a preliminary report. Thorax (1996) 1.70
Frozen section consultation. Utilization patterns and knowledge base of surgical faculty at a university hospital. Am J Clin Pathol (1995) 1.54
3' splice site selection in dicot plant nuclei is position dependent. Mol Cell Biol (1993) 1.49
Extent of antibiotic use in Taiwan shown by antimicrobial activity in urine. Lancet (1999) 1.43
Ultrasound-guided liver biopsy for parenchymal liver disease: an economic analysis. Dig Dis Sci (1998) 1.41
Cbl-b, a RING-type E3 ubiquitin ligase, targets phosphatidylinositol 3-kinase for ubiquitination in T cells. J Biol Chem (2000) 1.41
The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol (1999) 1.40
Mycoplasma pneumoniae infection complicated by lung abscess, pleural effusion, thrombocytopenia and disseminated intravascular coagulation. Pediatr Infect Dis J (1997) 1.39
Misleading radiograph. Br Dent J (1991) 1.39
Atherosclerotic aneurysm formation in an in situ saphenous vein graft. J Vasc Surg (1994) 1.39
Fatal cutaneous necrosis mimicking calciphylaxis in a patient with type 1 primary hyperoxaluria. Arch Dermatol (1995) 1.39
AHPBA/AJCC consensus conference on staging of hepatocellular carcinoma: consensus statement. HPB (Oxford) (2003) 1.39
Do corticosteroids reduce mortality from alcoholic hepatitis? A meta-analysis of the randomized trials. Ann Intern Med (1990) 1.38
Can the need for a physician as part of the pediatric transport team be predicted? A prospective study. Crit Care Med (1992) 1.37
Hindsight bias: an impediment to accurate probability estimation in clinicopathologic conferences. Med Decis Making (1988) 1.35
Diagnosis of Wilson's disease presenting as fulminant hepatic failure. Gastroenterology (1983) 1.33
Unusual serum lipoprotein abnormality induced by the vehicle of miconazole. N Engl J Med (1977) 1.32
Should all pregnant women be screened for hepatitis B? Ann Intern Med (1987) 1.31
Inhibition of phosphatidylinositol 3-kinase activity by association with 14-3-3 proteins in T cells. Proc Natl Acad Sci U S A (1995) 1.31
A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation. Bone Marrow Transplant (2004) 1.30
Optical coherence tomography of the esophagus and proximal stomach in health and disease. Am J Gastroenterol (2001) 1.29
Cbl promotes ubiquitination of the T cell receptor zeta through an adaptor function of Zap-70. J Biol Chem (2001) 1.27
High prevalence of latent tuberculosis infection in patients in end-stage renal disease on hemodialysis: Comparison of QuantiFERON-TB GOLD, ELISPOT, and tuberculin skin test. Infection (2008) 1.26
Protein kinase C mu is negatively regulated by 14-3-3 signal transduction proteins. J Biol Chem (1999) 1.26
Clinical characteristics of emphysematous pyelonephritis. J Microbiol Immunol Infect (2001) 1.26
Ligand-induced activation of chimeric receptors between the erythropoietin receptor and receptor tyrosine kinases. Proc Natl Acad Sci U S A (1994) 1.23
Mycotic aneurysm due to Burkholderia pseudomallei. Clin Infect Dis (1998) 1.23
The prophylactic effect of dexamethasone on postoperative nausea and vomiting in women undergoing thyroidectomy: a comparison of droperidol with saline. Anesth Analg (1999) 1.20
Comparison of the BACTEC MGIT 960 and BACTEC 460TB systems for detection of mycobacteria in clinical specimens. Ann Clin Lab Sci (2001) 1.20
Direct interaction between protein kinase C theta (PKC theta) and 14-3-3 tau in T cells: 14-3-3 overexpression results in inhibition of PKC theta translocation and function. Mol Cell Biol (1996) 1.20
Mycotic aneurysm due to non-typhi salmonella: report of 16 cases. Clin Infect Dis (1996) 1.19
Molecular cloning and functional expression of a cDNA encoding glycosylation-inhibiting factor. Proc Natl Acad Sci U S A (1993) 1.19
Reliability of the Muller maneuver and its association with sleep-disordered breathing. Laryngoscope (2000) 1.18
Expression of c-Myc and p53 correlates with clinical outcome in diffuse large B-cell lymphomas. Am J Clin Pathol (2000) 1.17
Carcinoma at the junction of the main hepatic ducts. Q J Med (1969) 1.17
Regulation of protein kinase Ctheta function during T cell activation by Lck-mediated tyrosine phosphorylation. J Biol Chem (2000) 1.17
Dexamethasone reduces nausea and vomiting after laparoscopic cholecystectomy. Br J Anaesth (1999) 1.14
Pyogenic liver abscess: clinical manifestations and value of percutaneous catheter drainage treatment. J Formos Med Assoc (1990) 1.14
Differential gene expression of livers from ApoE deficient mice. Life Sci (2000) 1.14
c-myc amplification in hepatocellular carcinoma predicts unfavorable prognosis. Mod Pathol (1996) 1.13
Quality-of-life assessments and chronic liver disease. Am J Gastroenterol (1998) 1.12
Coordinated regulation of the tyrosine phosphorylation of Cbl by Fyn and Syk tyrosine kinases. J Biol Chem (1998) 1.12
Expression of maize Adh1 intron mutants in tobacco nuclei. Plant J (1993) 1.11
Peripheral blood neutrophils in inflammatory bowel disease: morphological evidence of in vivo activation in active disease. Clin Exp Immunol (1991) 1.10
Error-tolerant pooling designs with inhibitors. J Comput Biol (2003) 1.09
Effects of silymarin on the resolution of liver fibrosis induced by carbon tetrachloride in rats. J Viral Hepat (2008) 1.09
Multicenter surveillance of antimicrobial resistance of major bacterial pathogens in intensive care units in 2000 in Taiwan. Microb Drug Resist (2001) 1.09
Role of benzathine penicillin G in prophylaxis for recurrent streptococcal cellulitis of the lower legs. Clin Infect Dis (1997) 1.09
The effect of copayments and income on the utilization of medical care by subscribers to Japan's National Health Insurance System. Int J Health Serv (1995) 1.08
Variation in tolerance and virulence in the chestnut blight fungus-hypovirus interaction. Appl Environ Microbiol (2000) 1.07
Implementation of clinical guidelines through an electronic medical record: physician usage, satisfaction and assessment. Int J Med Inform (2001) 1.07
Upregulation of endothelial heme oxygenase-1 expression through the activation of the JNK pathway by sublethal concentrations of acrolein. Toxicol Appl Pharmacol (2006) 1.07
Causal bacteria of pyogenic liver abscess. Taiwan Yi Xue Hui Za Zhi (1989) 1.07
Cryptococcus laurentii fungemia in a premature neonate. J Clin Microbiol (2001) 1.06
Correlation of serum immunoglobulin G Helicobacter pylori antibody titers with histologic and endoscopic findings in patients with dyspepsia. J Clin Gastroenterol (1997) 1.06
Chronic hepatitis C and superimposed nonalcoholic fatty liver disease. Liver (2001) 1.05
Evaluation of nutritional status in advanced metastatic cancer. Support Care Cancer (2003) 1.05
Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease. Liver Transpl (2001) 1.05
Endoscopic ultrasound cannot determine suitability for esophagectomy after aggressive chemoradiotherapy for esophageal cancer. Am J Gastroenterol (1999) 1.04
The use of dexamethasone for preventing postoperative nausea and vomiting in females undergoing thyroidectomy: a dose-ranging study. Anesth Analg (2000) 1.04
Diversity of Hypoviruses and Other Double-Stranded RNAs in Cryphonectria parasitica in North America. Phytopathology (1997) 1.04
Regulation of cyclin D1, DNA topoisomerase I, and proliferating cell nuclear antigen promoters during the cell cycle. Gene Expr (1995) 1.04
Variation in subcapsular liver structure and its significance in the interpretation of wedge biopsies. J Clin Pathol (1967) 1.04
Glutathione peroxidase and catalase modulate the genotoxicity of arsenite. Toxicology (1997) 1.03
Comparison of the Roche AMPLICOR MYCOBACTERIUM assay and Digene SHARP Signal System with in-house PCR and culture for detection of Mycobacterium tuberculosis in respiratory specimens. J Clin Microbiol (1996) 1.03
Measurement of d sigma/dM and forward-backward charge asymmetry for high-mass Drell-Yan e(+)e(-) pairs from pp macro collisions at square root of s = 1.8 TeV. Phys Rev Lett (2001) 1.02
Tyrosine phosphorylation and complex formation of Cbl-b upon T cell receptor stimulation. Oncogene (1999) 1.02
Vav-Rac1-mediated activation of the c-Jun N-terminal kinase/c-Jun/AP-1 pathway plays a major role in stimulation of the distal NFAT site in the interleukin-2 gene promoter. Mol Cell Biol (2001) 1.01
Shared idiotopes among monoclonal antibodies specific for A/PR/8/34 (H1N1) and X-31(H3N2) influenza viruses. Proc Natl Acad Sci U S A (1984) 1.00
Endothelial exposure to hypoxia induces Egr-1 expression involving PKCalpha-mediated Ras/Raf-1/ERK1/2 pathway. J Cell Physiol (2001) 0.99
Lateralizing value of asymmetric tonic limb posturing observed in secondarily generalized tonic-clonic seizures. Epilepsia (2000) 0.98
U-rich tracts enhance 3' splice site recognition in plant nuclei. Plant J (1996) 0.98
Olfactory receptor-like genes are located in the human major histocompatibility complex. Genomics (1995) 0.98
Benign fibrous tumor of the tunica vaginalis testis. Report of a case with light, electron microscopic, and immunocytochemical study, and review of the literature. Arch Pathol Lab Med (1992) 0.98